Skip to main content
. 2025 Aug 22;11(9):e1846. doi: 10.1097/TXD.0000000000001846

TABLE 4.

Cohort restricted to heart recipients only

Women ≤50 y (N = 8) Women >50 y (N = 6) Men ≤50 y (N = 7) Men >50 y (N = 19)
1-mo measures, mean (SD)
 ALC, K/µL 1.16 (1.08) 0.72 (0.36) 1.52 (0.91) 0.97 (0.67)
 CD4+, K/µL 0.50 (0.59) 0.34 (0.24) 0.84 (0.51) 0.44 (0.31)
 CD8+, K/µL 0.27 (0.30) 0.12 (0.07) 0.31 (0.26) 0.22 (0.19)
 CD3+, K/µL 0.78 (0.90) 0.47 (0.27) 1.16 (0.72) 0.67 (0.47)
 CD4+/CD8+ ratio 1.38 (0.93) 2.99 (2.57) 3.41 (2.13) 3.11 (2.51)
 Total IgG, mg/dL 592.14 (196.99) 378.33 (128.40) 514.17 (262.25) 617.63 (257.29)
6-mo measures, mean (SD)
 ALC, K/µL 0.99 (0.65) 0.60 (0.35) 1.21 (0.41) 0.92 (0.54)
 CD4+, K/µL 0.39 (0.37) 0.18 (0.15) 0.57 (0.05) 0.38 (0.24)
 CD8+, K/µL 0.25 (0.16) 0.15 (0.12) 0.26 (0.16) 0.19 (0.12)
 CD3+, K/µL 0.65 (0.55) 0.33 (0.12) 0.86 (0.15) 0.59 (0.31)
 CD4+/CD8+ ratio 1.24 (0.81) 1.76 (1.43) 2.94 (1.89) 2.70 (2.93)
 Total IgG, mg/dL 543.00 (220.45) 488.00 (238.52) 650.33 (397.61) 587.83 (181.11)

Mean values of ALC, lymphocyte subsets, and total IgG, stratified by age-sex category.

ALC, absolute lymphocyte count.